Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The COVID-19 outbreak: a snapshot from down under.
van Zandwijk N, Rasko JEJ. van Zandwijk N, et al. Expert Rev Anticancer Ther. 2020 Jun;20(6):433-436. doi: 10.1080/14737140.2020.1766974. Epub 2020 May 18. Expert Rev Anticancer Ther. 2020. PMID: 32419533 No abstract available.
Editorial: Emerging Therapies for Malignant Mesothelioma.
van Zandwijk N, Reid G, Baas P. van Zandwijk N, et al. Front Oncol. 2020 Jun 12;10:939. doi: 10.3389/fonc.2020.00939. eCollection 2020. Front Oncol. 2020. PMID: 32596157 Free PMC article. No abstract available.
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma.
Castelletti L, Yeo D, van Zandwijk N, Rasko JEJ. Castelletti L, et al. Among authors: van zandwijk n. Biomark Res. 2021 Feb 15;9(1):11. doi: 10.1186/s40364-021-00264-1. Biomark Res. 2021. PMID: 33588928 Free PMC article. Review.
Locoregional delivery of CAR-T cells in the clinic.
Sagnella SM, White AL, Yeo D, Saxena P, van Zandwijk N, Rasko JEJ. Sagnella SM, et al. Among authors: van zandwijk n. Pharmacol Res. 2022 Aug;182:106329. doi: 10.1016/j.phrs.2022.106329. Epub 2022 Jun 27. Pharmacol Res. 2022. PMID: 35772645 Review.
Malignant mesothelioma.
Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N. Kao SC, et al. Among authors: van zandwijk n. Intern Med J. 2010 Nov;40(11):742-50. doi: 10.1111/j.1445-5994.2010.02223.x. Intern Med J. 2010. PMID: 20298508 Review.
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.
Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, Williams M, Wright C, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, Brahmbhatt H, MacDiarmid JA, van Zandwijk N. Reid G, et al. Among authors: van zandwijk n. Ann Oncol. 2013 Dec;24(12):3128-35. doi: 10.1093/annonc/mdt412. Epub 2013 Oct 22. Ann Oncol. 2013. PMID: 24148817 Free article.
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
van Zandwijk N, Pavlakis N, Kao SC, Linton A, Boyer MJ, Clarke S, Huynh Y, Chrzanowska A, Fulham MJ, Bailey DL, Cooper WA, Kritharides L, Ridley L, Pattison ST, MacDiarmid J, Brahmbhatt H, Reid G. van Zandwijk N, et al. Lancet Oncol. 2017 Oct;18(10):1386-1396. doi: 10.1016/S1470-2045(17)30621-6. Epub 2017 Sep 1. Lancet Oncol. 2017. PMID: 28870611 Clinical Trial.
275 results